Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non–Small Cell Lung Cancer

Published:2019-06-01 Issue:6 Volume:5 Page:847
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Sun Alexander¹,Hu Chen²³,Wong Stuart J.⁴,Gore Elizabeth⁴,Videtic Gregory⁵,Dutta Swati⁶,Suntharalingam Mohan⁷,Chen Yuhchyau⁸,Gaspar Laurie E.⁹,Choy Hak¹⁰

Affiliation:

1. Princess Margaret Cancer Centre, Toronto, Ontario, Canada

2. NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania

3. Johns Hopkins University School of Medicine, Baltimore, Maryland

4. Medical College of Wisconsin, Milwaukee

5. Cleveland Clinic Foundation, Cleveland, Ohio

6. Michigan Cancer Research Consortium CCOP, Ann Arbor

7. University of Maryland Medical System, Baltimore

8. University of Rochester, Rochester, New York

9. University of Colorado, Denver

10. University of Texas Southwestern Medical Center, Dallas

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

http:///jamaoncology/article-pdf/5/6/847/17667013/jamaoncology_sun_2019_oi_180128.pdf

Reference61 articles.

1. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain.;Chen;Cancer,2007

2. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.;Pöttgen;J Clin Oncol,2007

3. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.;Mamon;J Clin Oncol,2005

4. Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer.;Keith;Am J Clin Oncol,2002

5. Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis.;Ceresoli;Cancer,2002

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Vesicle- and Mitochondria-Based Targeting of Non-Small Cell Lung Cancer Response to Radiation: Challenges and Perspectives;Cancers;2024-06-15

2. Editorial: Real-world data and real-world evidence in lung cancer;Frontiers in Oncology;2024-06-07

3. Prevention of Brain Metastases: A New Frontier;Cancers;2024-06-04

4. Comprehensive genomic and clinical analyses identify APOBEC mutational signatures as a brain metastasis risk factor in lung adenocarcinoma patients;Translational Oncology;2024-05

5. Risk factors for brain metastases in locally advanced non-small cell lung cancer patients treated with radical radiotherapy;Journal of Thoracic Disease;2024-01